SYRA

Syra Health Corp. (SYRA) | Rumor.io

Syra Health

SYRA

Attention (50-day avg)0%

Attention rank (50-day avg)#3,453

Bullish sentiment (50-day avg)100%

Price to earnings ratio87.8

Market capitalization11.9M

Earnings per share0.01

Dividend yield (TTM)—

Revenue (annual)7.2M

Net income (annual)-896.3K

Social

What share of all stock conversation is about SYRA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jan 18

$SYRA's team is actively working on future autonomous agent development.
A video demonstration of the Syra agent in different use cases is requested.
The Syra agent is intended to be user-friendly and "dummy-proof" for maximum engagement.

Generated by AI

Sentiment

Of the messages about SYRA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	94.4% +7.29
Bearish	—	—	—	5.6% -7.29

Bullish· Nov 25

The company is building a real AI trading infrastructure with a strong foundation in StrictVM and adding a smarter agent on top of it, testing multiple LLMs, and opening everything through an API.
The pace of shipping and the upcoming API integration are expected to drive significant growth and make the asset a leader in the microcap charts.
The team is delivering on their promises, and the asset is undervalued, with a strong chart setup and underlying tech that gives it a unique edge in the x402-native AI trading assistant on Solana.

Bearish· Jan 7

The stock's float is extremely low at 5 million shares, making it vulnerable to manipulation.
The stock has a history of being destroyed by naked shorts, particularly in the Byedumbs market.
The stock's attempt to break above key resistance levels has been unsuccessful, with it struggling to stay above the VWAP.

Generated by AI

Topics

Of the messages about SYRA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	—	54.17%
Analysts	—	—	—	0%
Announcements	—	—	—	45.83%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%

Announcements· Jan 7

Syra Health Corp. (SYRA) won a new workforce contract with the Washington D.C. government, valued at up to $1 million.
The company also announced an extension of its existing contract with the Indiana Family and Social Services Administration's NeuroDiagnostic Institute, increasing its value to $18.7 million.
This is Syra Health Corp.'s fourth contract with the Washington D.C. government, demonstrating a strong client relationship.

Technical Analysis· Feb 9

$SYRA is expected to bounce at $8, with a potential re-test of that level today.
A bull flag is forming on the 30-minute chart, with a potential breakout coming soon, and the stock is riding the 20-period EMA nicely.
A MACD cross is imminent, and if $SYRA breaks $4.08, it could see prices of $4.50 or higher.

Generated by AI

Community

Of the messages about SYRA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	12.28%
Newcomers	—	—	—	87.72%

Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that, in partnership with HealthSync, it has been accepted into the CMS (Centers for Medicare & Medicaid) ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model. Inclusion in the federal program reinforces the Company's commitment to helping providers improve

27d agoYahoo Finance

This Microcap Just Proved Its First Profitable Quarter Wasn't a Fluke

Updated Price for S&P 500 VIX (CFE: VIV24). Charting, Price Performance, News & Related Contracts.

1mo agoThe Globe and Mail

Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter

1mo agoYahoo Finance

Syra Health To Announce Second Quarter 2026 Financial Results

Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that it will report financial results for the three months ended June 30, 2026, on Tuesday, August 11, 2026.

1mo agoYahoo Finance

Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy

Dr. McMahon will serve in this role in a fractional capacity, supporting Syra Health's growth strategy by strengthening engagement with healthcare stakeholders and expanding opportunities across both commercial and public healthcare sectors. Dr. McMahon brings deep clinical expertise and significant experience aligned with Syra Health's solutions, "...

2mo agoNasdaq

Also Discussed

Investors talking about SYRA also mention

#	Name	Attention
1	J-Long Group Limited Class A Ordinary SharesJL	0%new
2	Beamr Imaging Ltd. Ordinary ShareBMR	0%0
3	Hitek Global Inc.HKIT	0%0
4	Primis Financial Corp.FRST	0%0
5	Sana Biotechnology Inc.SANA	0%0
6	CHEA - Chenghe Acquisition Co.	——
7	ROI - RiskOn International, Inc.	——
8	LVTX - LAVA Therapeutics N.V.	——
9	MINM - Minim, Inc.	——
10	Saul Centers, Inc.BFS	0%new

Syra Health Corp.

Healthcare
Medical Care Facilities

Syra Health Corp. is a specialized company operating in the healthcare services sector. It primarily focuses on providing comprehensive solutions that aim to enhance healthcare delivery and patient outcomes. The company offers a diverse range of services, including health literacy programs, telemedicine solutions, and healthcare staffing services, catering to the evolving needs of the healthcare industry. Additionally, Syra Health Corp. places a strong emphasis on leveraging technology to improve efficiency and accessibility in healthcare settings, impacting both urban and remote areas. By addressing crucial health education and service delivery challenges, the company plays a significant role in shaping the future of healthcare services. As healthcare continues to be a pivotal industry globally, Syra Health Corp.'s contributions assist in bridging gaps within the system, ultimately supporting the industry’s shift towards more patient-centered and efficient care models.

Website

Location

1119 Keystone Way North

Carmel, IN, 46032

United States

Social

What share of all stock conversation is about SYRA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jan 18

$SYRA's team is actively working on future autonomous agent development.
A video demonstration of the Syra agent in different use cases is requested.
The Syra agent is intended to be user-friendly and "dummy-proof" for maximum engagement.

Generated by AI

Sentiment

Of the messages about SYRA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	94.4% +7.29
Bearish	—	—	—	5.6% -7.29

Bullish· Nov 25

The company is building a real AI trading infrastructure with a strong foundation in StrictVM and adding a smarter agent on top of it, testing multiple LLMs, and opening everything through an API.
The pace of shipping and the upcoming API integration are expected to drive significant growth and make the asset a leader in the microcap charts.
The team is delivering on their promises, and the asset is undervalued, with a strong chart setup and underlying tech that gives it a unique edge in the x402-native AI trading assistant on Solana.

Bearish· Jan 7

The stock's float is extremely low at 5 million shares, making it vulnerable to manipulation.
The stock has a history of being destroyed by naked shorts, particularly in the Byedumbs market.
The stock's attempt to break above key resistance levels has been unsuccessful, with it struggling to stay above the VWAP.

Generated by AI

Topics

Of the messages about SYRA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	—	54.17%
Analysts	—	—	—	0%
Announcements	—	—	—	45.83%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%

Announcements· Jan 7

Syra Health Corp. (SYRA) won a new workforce contract with the Washington D.C. government, valued at up to $1 million.
The company also announced an extension of its existing contract with the Indiana Family and Social Services Administration's NeuroDiagnostic Institute, increasing its value to $18.7 million.
This is Syra Health Corp.'s fourth contract with the Washington D.C. government, demonstrating a strong client relationship.

Technical Analysis· Feb 9

$SYRA is expected to bounce at $8, with a potential re-test of that level today.
A bull flag is forming on the 30-minute chart, with a potential breakout coming soon, and the stock is riding the 20-period EMA nicely.
A MACD cross is imminent, and if $SYRA breaks $4.08, it could see prices of $4.50 or higher.

Generated by AI

Community

Of the messages about SYRA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	12.28%
Newcomers	—	—	—	87.72%

Syra Health

Social

Jan 18

Sentiment

Bullish· Nov 25

Bearish· Jan 7

Topics

Announcements· Jan 7

Technical Analysis· Feb 9

Community

News

Syra Health wins Mississippi public health analytics contract

Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy

This Microcap Just Proved Its First Profitable Quarter Wasn't a Fluke

Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter

Syra Health To Announce Second Quarter 2026 Financial Results

Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy

Also Discussed

Syra Health Corp.

Company Information

Location

News

Syra Health wins Mississippi public health analytics contract

Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy

This Microcap Just Proved Its First Profitable Quarter Wasn't a Fluke

Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter

Syra Health To Announce Second Quarter 2026 Financial Results

Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy

Also Discussed

Social

Jan 18

Sentiment

Bullish· Nov 25

Bearish· Jan 7

Topics

Announcements· Jan 7

Technical Analysis· Feb 9

Community